Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Minority Interest: 2023

  • Ironwood Pharmaceuticals' Minority Interest was N/A to -$2.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$2.5 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2009, which is N/A change from last year.
  • According to the latest figures from Q3 2023, Ironwood Pharmaceuticals' Minority Interest is -$2.5 million, which was down 129.54% from -$1.1 million recorded in Q2 2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Minority Interest registered a high of -$1.1 million during Q2 2023, and its lowest value of -$2.5 million during Q3 2023.
  • Its 1-year average for Minority Interest is -$1.8 million, with a median of -$1.8 million in 2023.